Verona Pharma Plc (VRNA) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Verona Pharma Plc  (NASDAQ: VRNA)


Verona Pharma Plc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Verona Pharma Plc's ROI in the second quarter of 2025?
Verona Pharma Plc recorded a cumulative net loss of $-81 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -17.1%.

Within the Healthcare sector 290 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2025 quarter, so far to 3023, from total ROI ranking in the first quarter of 2025 at 3475.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM 46.75 % 44.98 % 24.7 % 18.9 % 16.93 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 543 488 514 354 386
Return On Investment (TTM) -17.1 % -37.65 % -45.43 % -45.06 % -38.77 %
VRNA's Overall Ranking # 3023 # 3475 # 2364 # 3249 # 2985
Seq. Investment Change TTM 9.04 % 14.08 % 11.89 % 5.44 % 7.73 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -81 -164 -173 -154 -125

VRNA Company Profile >> Back to VRNA Roi Comparisons >> See Annual VRNA Return On Investment



Return On Investment VRNA's Ranking
Within: No.
Industry # 98
Sector # 291
Overall # 3023

Return On Investment Statistics
High Average Low
-18.21 %
-33.08 %
-50.68 %
(Sep 30 2023)   (Sep 30 2022)



  News about Verona Pharma Plc Return on Investment ROI

Verona Pharma Bolsters Leadership with Appointment of Andrew Fisher as General Counsel amid Financial Challenges

March 4, 2024


Verona Pharma Plc, a leading biopharmaceutical company specializing in the development of innovative respiratory medicines, has recently announced the appointment of Mr. Andrew Fisher as their new General Counsel. This development comes as the company strives to bolster its executive team and drive forward its strategic goals.
Andrew Fisher brings with him a wealth of legal expertise and experience, making him an ideal fit for the role. As General Counsel, he will be responsible for overseeing all legal affairs of Verona Pharma and providing guidance to the executive management team. This move aims to strengthen the company s legal capabilities and ensure compliance with relevant regulations.





Financial Statements
Verona Pharma Plc's II. Quarter Investments $ 543 Millions VRNA's Balance sheet
Verona Pharma Plc's II. Quarter Income $ 12 Millions Quarterly VRNA's Income Statement
VRNA's Income by Division See VRNA's Income by Division


VRNA Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 514 352 275 162 195
Y / Y Investment Growth 46.16 % 27.91 % 69.86 % -17.18 % 356.04 %
Net Income in Millions -173 -54 -69 -56 -65
Y / Y Net Income Growth - - - - -
Annual Return On Investment -33.75 % -15.47 % -25 % -34.35 % -33.35 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VRNA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VRNA's Competitors
Subscribers only: Roi for Verona Pharma Plc's Suppliers
Subscribers only: Return On Investment for VRNA's Customers

Other Ratios
VRNA's Roa VRNA's Inventory Turnover Ratio VRNA's Growth Rates VRNA's Dividend Statistics
VRNA's Profitability Ratios VRNA's Asset Turnover Ratio VRNA's Dividend Growth
VRNA's Roe VRNA's Valuation Ratios VRNA's Financial Strength Ratios VRNA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.